Company: PMVP
Filing Date: 2025-04-25
Form Type: DEFA14A
Source: 0001140361-25-015612
Chunk: 0

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEFA14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant☐ Check the appropriate box:

| ☐ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |

| ☐ | Definitive Proxy Statement |

| ☒ | Definitive Additional Materials |

| ☐ | Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-2 |

| PMV PHARMACEUTICALS, INC.                                                |
| (Name of Registrant as Specified In Its Charter)                         |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |

Payment of Filing Fee (Check the appropriate box):

| ☒ | ​ | ​ | No fee required.                                                         |
| ☐ | ​ | ​ | Fee paid previously with preliminary materials.                          |
| ☐ | ​ | ​ | Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. |